Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Free Articles

Week in Review: China Biopharmas Book $9 Billion in Deals During JP Morgan Conference Week
Week in Review: 2024 Kicks Off with Three Deals Worth a Total of $4 Billion
Week in Review: $1.7 Billion Collaboration between Elpiscience and Astellas is Final 2023 Deal
Week in Review: Two Billion-Dollar Deals as 2023 Nears End: Hansoh-GSK; Nona-Pfizer
Week in Review: SystImmune Out-Licenses Global Rights for ADC to BMS in $8.4 Billion Deal
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital